U.S. Would Gain Power to Negotiate Drug Prices Under Manchin-Schumer Bill

Listen to article (2 minutes) A deal between Senate Democrats has revived legislation to significantly expand…

Pharma Is Immune to a Recession, but Not to Washington

One looming problem for the pharma industry is a surprise deal in Washington this week that…

Drugmakers Hope New Heart Drugs Boost Sales, Revive Market

The once lucrative heart-drug market is now poised to make a comeback, but at the cost…

Long Covid is an elusive target for Big Pharma

This is the second column in the three-part Heard on the Street series on Long Covid.…

Big Pharma will not grant bail to battered biotech

Share Market It may have been in a recession, but the Biotechnology Index has fallen off…

Bristol-Myers to buy Turning Point Therapeutics for $4.1 billion

Bristol-Myers Squibb Company said it has agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Deepening…